CEST MRI quantification procedures for breast cancer treatment‐related lymphedema therapy evaluation
- 21 October 2019
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 83 (5) , 1760-1773
Abstract
Purpose: To quantify chemical exchange saturation transfer contrast in upper extremities of participants with lymphedema before and after standardized lymphatic mobilization therapy using correction procedures for B0 and B1 heterogeneity, and T1 relaxation.Methods: Females with (n = 12) and without (n = 17) breast cancer treatment‐related lymphedema (BCRL) matched for age and body mass index were scanned at 3.0T MRI. B1 efficiency and T1 were calculated in series with chemical exchange saturation transfer in bilateral axilla (B1 amplitude = 2µT, Δω = ±5.5 ppm, slices = 9, spatial resolution = 1.8 × 1.47 × 5.5 mm3). B1 dispersion measurements (B1 = 1‐3 µT; increment = 0.5 µT) were performed in controls (n = 6 arms in 3 subjects). BCRL participants were scanned pre‐ and post‐manual lymphatic drainage (MLD) therapy. Chemical exchange saturation transfer amide proton transfer (APT) and nuclear Overhauser effect (NOE) metrics corrected for B1 efficiency were calculated, including proton transfer ratio (PTR'), magnetization transfer ratio asymmetry , and apparent exchange‐dependent relaxation (AREX'). Nonparametric tests were used to evaluate relationships between metrics in BCRL participants pre‐ versus post‐MLD (two‐sided P < 0.05 required for significance).Results: B1 dispersion experiments showed nonlinear dependence of Z‐values on B1 efficiency in the upper extremities; PTR' showed < 1% mean fractional difference between subject‐specific and group‐level correction procedures. PTR'APT significantly correlated with T1 (Spearman's rho = 0.57, P < 0.001) and body mass index (Spearman's rho = −0.37, P = 0.029) in controls and with lymphedema stage (Spearman's rho = 0.48, P = 0.017) in BCRL participants. Following MLD therapy, PTR'APT significantly increased in the affected arm of BCRL participants (pre‐ vs. post‐MLD: 0.41 ± 0.05 vs. 0.43 ± 0.03, P = 0.02), consistent with treatment effects from mobilized lymphatic fluid.Conclusion: Chemical exchange saturation transfer metrics, following appropriate correction procedures, respond to lymphatic mobilization therapies and may have potential for evaluating treatments in participants with secondary lymphedema.Keywords
Funding Information
- National Institutes of Health (NIH)/National Institute of Nursing Research (1R01NR015079)
- Lipedema Foundation Postdoctoral Fellowship
This publication has 45 references indexed in Scilit:
- On B1 inhomogeneity correction of in vivo human brain glutamate chemical exchange saturation transfer contrast at 7TMagnetic Resonance in Medicine, 2012
- Seeing it through: translational validation of new medical imaging modalitiesBiomedical Optics Express, 2012
- Assessment of Lymphatic Contractile Function After Manual Lymphatic Drainage Using Near-Infrared Fluorescence ImagingArchives of Physical Medicine and Rehabilitation, 2011
- Chemical exchange saturation transfer (CEST): What is in a name and what isn't?Magnetic Resonance in Medicine, 2011
- Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesNature Medicine, 2010
- Characterization of ex vivo healthy human axillary lymph nodes with high resolution 7 Tesla MRIEuropean Radiology, 2010
- Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experimentsMagnetic Resonance in Medicine, 2009
- Actual flip‐angle imaging in the pulsed steady state: A method for rapid three‐dimensional mapping of the transmitted radiofrequency fieldMagnetic Resonance in Medicine, 2006
- T1 Measurements incorporating flip angle calibration and correction in vivoJournal of Magnetic Resonance, 2006
- Front-Loaded Infusion Therapy of rT-PA During Active MenstruationAngiology, 1994